All In Biotech

Free tool

FAERS Monitor: Dyna-Hex 2

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

FDA's data service returned an error (500). The numbers below may be missing or incomplete.

Reports naming NDA 019422 or its brand name (Dyna-Hex 2, Chlorhexidine Gluconate). Reports on generic versions are filed under their own applications.

Reports

7,749

Serious

6,519

84% of reports

Hospitalization

3,787

Death reported

2,710

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

Nothing to show.

Reports by year received

View as table
YearReports
200428
200519
200621
200738
200889
200995
2010151
2011160
2012163
201364
201484
2015132
2016241
2017276
2018297
2019313
2020405
2021681
2022605
2023510
20241,323
20251,535
2026519

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,410 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.